Carrie A Mohila, M.D., Ph.D.

Professor

mohila@bcm.edu

Professor: Pathology & Immunology
Baylor College of Medicine
Houston, TX, US

PhD from Drexel University College Of Medicine: 06/2005 - Philadelphia, PA, United States; Neuroscience

MD from Drexel University College Of Medicine: 06/2005 - Philadelphia, PA, United States

Residency at Dartmouth Hitchcock Medical Center: 06/2009 - Hanover, New Hampshire, United States; Anatomic & Clinical Pathology

Clinical Fellowship at University Of Virginia: 06/2011 - Charlottesville, VA, United States; Neuropathology

VIICTR Publications List

Yu K, Lin CJ, Hatcher A, Lozzi B, Kong K, Huang-Hobbs E, Cheng YT, Beechar VB, Zhu W, Zhang Y, Chen F, Mills GB, Mohila CA, Creighton CJ, Noebels JL, Scott KL, Deneen B.. " PIK3CA Variants Selectively Initiate Brain Hyperactivity During Gliomagenesis " Nature. 2020 Feb ; 578 (7793) : 166-171.
Pubmed PMID: 31996845.
Ding X, Jo J, Wang CY, Cristobal CD, Zuo Z, Ye Q, Wirianto M, Lindeke-Myers. " The Daam2-VHL-Nedd4 axis governs developmental and regenerative oligodendrocyte differentiation " Genes Dev. 2020 Sep 1; 34 (17-18) : 1177-01189.
Pubmed PMID: 32792353.
Glasgow SM, Carlson JC, Zhu W, Chaboub LS, Kang P, Lee HK, Clovis YM, Lozzi BE, McEvilly RJ, Rosenfeld MG, Creighton CJ, Lee SK, Mohila CA, Deneen B. " Glia-specific enhancers and chromatin structure regulate NFIA expression and glioma tumorigenesis " Nat Neurosci. 2017 Sep ;
Pubmed PMID: 28892058.
Hp1bp3 loss links chromatin reorganization to metabolic vulnerability in glioma.. " ;
Intracranial mesenchymal tumor, FET::CREB fusion-positive: An integrative analysis of 81 cases.. " ;